| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/25/2009 | CA2708409A1 Process for recovering flunixin from pharmaceutical compositions |
| 06/25/2009 | CA2707980A1 Misuse preventative, controlled release formulation |
| 06/25/2009 | CA2707453A1 Pharmaceutical compositions |
| 06/25/2009 | CA2706730A1 Single layered controlled release therapeutic system |
| 06/25/2009 | CA2706655A1 Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, and at least one film-forming agent methods for preparing same, and uses thereof |
| 06/25/2009 | CA2699496A1 Solid inorganic/organic hybrid with modified surface |
| 06/25/2009 | CA2699480A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates |
| 06/24/2009 | EP2072051A1 Combination of azelastine and mometasone |
| 06/24/2009 | EP2072049A2 Solid valsartan pharmaceutical compositions |
| 06/24/2009 | EP2072044A1 Pharmaceutical dosage form comprising a liquid or flowable core composition |
| 06/24/2009 | EP2072043A2 Mesalazine tablet |
| 06/24/2009 | EP2072042A1 Active pharmaceutical ingredient on solid support, amorphous and with improved solubility |
| 06/24/2009 | EP2072041A1 Film-coated tablets containing drospirenone as active agent and method for the preparation thereof |
| 06/24/2009 | EP2072040A1 Therapeutic use of nucleic acid micropheres |
| 06/24/2009 | EP1983965A4 Photodynamic cosmetic procedure and healing method |
| 06/24/2009 | EP1874278B1 Compositions containing micronized tanaproget |
| 06/24/2009 | EP1686959B1 Pharmaceutical formulations employing short-chain sphingolipids and their use |
| 06/24/2009 | EP1599184A4 Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same |
| 06/24/2009 | EP1556026B1 Novel pharmaceutical formulations of modafinil |
| 06/24/2009 | EP1520000A4 Catalyst for conversion processes |
| 06/24/2009 | EP1509243A4 Topical drug delivery using phosphatidylcholine |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/24/2009 | EP1314436B1 Antiviral composition comprising interferon in the form of nose drops |
| 06/24/2009 | EP1126785B1 Manganese compositions and methods for mri |
| 06/24/2009 | CN101466361A Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient flux |
| 06/24/2009 | CN101466360A Multi-membrane immunoisolation system for cellular transplant |
| 06/24/2009 | CN101466359A Fast release paracetamol tablets |
| 06/24/2009 | CN101466358A Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds |
| 06/24/2009 | CN101466357A Direct cellular energy delivery system |
| 06/24/2009 | CN101466355A Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties |
| 06/24/2009 | CN101466354A Type-2 diabetes combination wafer |
| 06/24/2009 | CN101466353A Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic application |
| 06/24/2009 | CN101461792A Gelatine enteric capsule shell material |
| 06/24/2009 | CN101461791A Huperzine A capsule and preparation method thereof |
| 06/24/2009 | CN101461790A Lamivudine tablet and preparation method |
| 06/24/2009 | CN101461789A Technique for preparing metronidazole benzoate dispersible tablet |
| 06/24/2009 | CN101461788A Phloroglucine orally disintegrating tablet and preparation method thereof |
| 06/24/2009 | CN101461787A Hydroxycamptothecin nano crystal lyophilized powder for injection preparation and preparation method thereof |
| 06/24/2009 | CN101461786A PLA/PLGA shell-core microballoons prepared by oil in water-solid in oil method, and preparation method thereof |
| 06/24/2009 | CN101461785A Oil in water-oil in oil-water in oil method for preparing microballoons |
| 06/24/2009 | CN101461784A Method for preparing nano magnetic microballoons and anticancer oral preparation prepared using the method |
| 06/24/2009 | CN101461783A Netilmicin sulphate nano micelle preparation for intravenous injection and preparation method thereof |
| 06/24/2009 | CN101461782A Sub-microemulsion preparation for levocarnitine injection and preparation method thereof |
| 06/24/2009 | CN101461781A Gernebcin eye drops without bacteriostatic agent and preparation method thereof |
| 06/24/2009 | CN101461780A Carteolol hydrochloride eye drops without bacteriostatic agent and preparation method thereof |
| 06/24/2009 | CN101461779A Disposable ofloxacin eye drops without bacteriostatic agent and preparation method thereof |
| 06/24/2009 | CN101461778A Disposable levofloxacin hydrochloride eye drops without bacteriostatic agent and preparation method thereof |
| 06/24/2009 | CN101461777A Disposable levofloxacin hydrochloride eye drops without bacteriostatic agent and preparation method thereof |
| 06/24/2009 | CN101461776A Sodium hyaluronate eye drops without bacteriostatic agent and preparation method thereof |
| 06/24/2009 | CN101461775A Chloromycetin eyedrops without bacteriostatic agent and preparation method thereof |
| 06/24/2009 | CN101461774A Oral liquid containing trimetazidine dihydrochloride and preparation method thereof |
| 06/24/2009 | CN101461773A Method for preparing medicament with various shapes and colors for taking medicine distinctively |
| 06/24/2009 | CN100503637C Glucagon-like peptide analog, its composition and its using method |
| 06/24/2009 | CN100503598C Improved chemical process and pharmaceutical formulation |
| 06/24/2009 | CN100502949C Polymer coated particle of slow release |
| 06/24/2009 | CN100502948C Magnetic high polymer nanometer micro-balls type medicine carrying system, and its preparation method |
| 06/24/2009 | CN100502937C Chinese medicine composition for treating cardiovascular disease and its preparing method |
| 06/24/2009 | CN100502915C Chinese medicinal herb capsule for treating hyperosteogeny |
| 06/24/2009 | CN100502906C External-applied ointment of skin tinea and preparation thereof |
| 06/24/2009 | CN100502903C Anshenning dripping pill for treating neurosism and its preparing method |
| 06/24/2009 | CN100502902C Honeysuckle and baical skullcap root combination, oral preparation and injection preparation containing same, its preparing method and application |
| 06/24/2009 | CN100502900C Astragalus root dripping pill and its preparing method |
| 06/24/2009 | CN100502884C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/24/2009 | CN100502883C Cornel extract oral medicine compositions of low irritation to gastrointestinal tract and its preparation |
| 06/24/2009 | CN100502877C Sustained-release prostaglandin I derivative preparation |
| 06/24/2009 | CN100502874C Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 06/24/2009 | CN100502873C Formulations containing cephalosporin |
| 06/24/2009 | CN100502872C Effervescence tablet of sulfogaiacol pentoxyverine and its preparation technique |
| 06/24/2009 | CN100502852C Flurbiprofenbab preparation and its preparation method |
| 06/24/2009 | CN100502844C Toxin-expelling face-nourishing tablets and preparing method |
| 06/24/2009 | CN100502843C Chinese medicine for treating mammary gland cystoma, mammitis and preparation method of its film coated tablet |
| 06/24/2009 | CN100502842C Dispersing tablets of nizatidine, and its preparation method |
| 06/24/2009 | CN100502841C Antivirus chewing tablet and its preparation method |
| 06/24/2009 | CN100502840C Medication for treating chronic rhinitis and nasal sinusitis |
| 06/24/2009 | CN100502839C Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 06/24/2009 | CN100502838C Toxin-expelling and face nourishing granules and preparing method |
| 06/24/2009 | CN100502837C Lignum liposome and its preparation process and application |
| 06/24/2009 | CN100502836C Chinese medicinal preparation for treating osteopathia and its preparation method |
| 06/24/2009 | CN100502835C Curcuma zedoary oil submicro emulsion and its preparation method |
| 06/24/2009 | CN100502834C Amphotericin B structured emulsion |
| 06/24/2009 | CN100502833C Novel preparing method for Tibetan medicine Qingpeng ointment |
| 06/24/2009 | CN100502821C Application of hydrogel plaster composition in preparing local formulation and the pharmaceutical kits |
| 06/23/2009 | USRE40792 treating CANCER, PMS, MENOPAUSE AND HYPERCHOLESTEROLEMIA with plant extract of soya or clover and isoflavones from Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides; dosage forms |
| 06/23/2009 | USRE40786 IMMUNOSTIMULAnts COMPOSITION COMPRISING IMMUNOGENIC SUBSTANCE ENCAPSULATED IN POLYLACTIDE-CO-GLYCOLIDE MATRIX; vaccine for HIV-1 |
| 06/23/2009 | US7550445 Inclusion complex in a beta-cyclodextrin, preferably, sulfobutyl ether beta-cyclodextrin, in the form of an injectable material; reducing irritation normally caused by aripiprazole at an intramuscular injection site; for treating schizophrenia |
| 06/23/2009 | US7550443 prosthesis, stent medical device has a multilayer with bioactive agent-releasing coatings having heparin activity; coatings are formed using biostable or biodegradable polymeric material and photoreactive groups; absorbs light at different wavelength, without hurting the bioactive agent |
| 06/23/2009 | US7550441 Controlled release polymer nanoparticle containing bound nucleic acid ligand for targeting |
| 06/23/2009 | US7550440 aqueous emulsion for the treatment of rosacea skin disorders, acne, dermatitis; Glycerol, Isopropyl palmitate, Cetyl alcohol, Stearyl monostearate, Oleyl alcohol, Ceteareth-20; good cosmetic properties and long shelf-life with minimum of 2 years |
| 06/23/2009 | US7550437 administering a protein agonist for protease-activated receptor (PAR-2); side effects reduction; peptidase inhibitors (amistatins); drug delivery; biodrugs as antisecretory agents |
| 06/23/2009 | US7550434 preparing a sealed vial or sealed cartridge for storage stability, resist to oxidation and chemical; including BUFFER AND A POLYOL; MANNITOL, BUFFER OF AN ACETATE OR TARTRATE, M-CRESOL OR BENZYL ALCOHOL PRESERVATIVE; parathyroid hormone for treating osteoporosis |
| 06/23/2009 | US7550282 Biological glue based on thrombin-conjugated nanoparticles |
| 06/23/2009 | US7550164 Compositions containing a nopal cactus isolate and method for making same |
| 06/23/2009 | US7550158 Controlled release by extrusion of solid amorphous dispersions of drugs |
| 06/23/2009 | US7550157 Method for the preparation of polymeric micelle via phase separation of block copolymer |
| 06/23/2009 | US7550156 For pharmaceutical, agrochemical, water treatment, water softening, fabric softening or detergent compositions; cross-linked polyacrylate water absorbent disintegration agent; starch or derivative water transport agent |
| 06/23/2009 | US7550155 two excipients are: a block co-polymer (for example, a poloxamer ), and a polyethylene glycol (PEG); with this synergistic mixture it is possible to dissolve or suspend higher amounts of propofol and other lipophilic compounds while, at the same time, using smaller amounts of these excipients |
| 06/23/2009 | US7550153 Pantoprazole multiparticulate formulations |
| 06/23/2009 | US7550145 Adjuvant compositions |
| 06/23/2009 | US7550134 fluorene moiety attached to polymer backbone such as derived from an octadecene-maleic anhydride copolymer through a neopentyl glycol tether; stabilizing dibenzoylmethane compounds in sunscreens; waterproofing surfaces |
| 06/23/2009 | US7550133 comprise respiratory drug condensation aerosol particles; selected from the group consisting of beta -adrenergics, methylxanthines, anticholinergics, corticosteroids, mediator-release inhibitors, anti-leukotriene drugs, asthma inhibitors etc |